Neuropace, Inc. · NASDAQ:NPCE

Morrell Martha had 358 Neuropace, Inc. shares withheld for tax (Form 4)

Traded Aug 27, 2026 · Filed Aug 28, 2026

On Aug 27, 2026, Morrell Martha (CHIEF MEDICAL OFFICER) had 358 Neuropace, Inc. shares withheld for tax at US$14.13 for US$5,059, leaving 51,692 shares. Filed Aug 28, 2026 (Form 4).

Withheld for tax
358 shares
Price
US$14.13
Value
US$5,059
Holding after
51,692 shares
Trading plan
No
Role
CHIEF MEDICAL OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 27, 2026Common StockShares withheld for tax358US$14.1351,692Direct

Source

View original at SEC

Related